Synopsys Inc
NASDAQ:SNPS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
463.97
621.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Synopsys Inc
Synopsys Inc
Cash from Financing Activities
Synopsys Inc
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Synopsys Inc
NASDAQ:SNPS
|
Cash from Financing Activities
-$465.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-16%
|
|
|
Salesforce Inc
NYSE:CRM
|
Cash from Financing Activities
-$10.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-97%
|
CAGR 10-Years
-53%
|
|
|
|
Palantir Technologies Inc
NYSE:PLTR
|
Cash from Financing Activities
$218.8m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Applovin Corp
NASDAQ:APP
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuit Inc
NASDAQ:INTU
|
Cash from Financing Activities
-$485m
|
CAGR 3-Years
44%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-4%
|
|
|
Adobe Inc
NASDAQ:ADBE
|
Cash from Financing Activities
-$2.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-17%
|
|
Synopsys Inc
Glance View
In the tightly-knit world of semiconductor design, Synopsys Inc. stands as a titan, quietly powering the intricate process behind the chips that drive today’s technology. Founded in 1986, the California-based company has carved out a critical niche by providing Electronic Design Automation (EDA) tools, which are indispensable for chip manufacturers aiming for efficiency and precision. Think of their software as the sculptor's chisel, indispensable for crafting the silicon gardens that populate everything from smartphones to servers. Synopsys’s offerings include tools for design verification, which ensure that chips function as intended without costly rework, and for design for manufacturing, confirming designs can be reliably produced at a high yield. This software automates and streamlines complex design processes, enabling companies to reduce time-to-market and development costs—a crucial competitive edge in an industry characterized by rapid change. Synopsys thrives on a business model primarily driven by software licenses and subscriptions. Its clients, a mélange of semiconductor giants and fledgling design firms, pay for access to Synopsys’s tools, with arrangements typically spanning multiple years. Over time, this model has evolved to incorporate software-as-a-service (SaaS) elements, allowing the company to capture recurring revenue streams. Additionally, with the semiconductor landscape expanding to new horizons—augmented reality, AI, and beyond—Synopsys has diversified its portfolio to encompass IP licensing. This offering provides pre-designed and verified circuit components that clients can plug directly into their chip designs, further enhancing design speed and efficiency. In essence, Synopsys operates at the core of technological innovation, equipping engineers with the sophisticated tools and templates necessary to create the future of computing.
See Also
What is Synopsys Inc's Cash from Financing Activities?
Cash from Financing Activities
-465.7m
USD
Based on the financial report for Jul 31, 2024, Synopsys Inc's Cash from Financing Activities amounts to -465.7m USD.
What is Synopsys Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-16%
Over the last year, the Cash from Financing Activities growth was 62%. The average annual Cash from Financing Activities growth rates for Synopsys Inc have been 7% over the past three years , 5% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
